BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in FHTX — Foghorn Therapeutics Inc.

CIK 1107261 HOUSTON, TX

Position in FHTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$437,248

+$80,660 QoQ

Shares Held

89,600

+20.1% QoQ

Ownership

0.151%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#32

of 102 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. FHTX ranks #45 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$437,248	89,600	+20.1%	Shares	Sole	2026-08-14
2026-03-31	$356,588	74,600	0.0%	Shares	Sole	2026-05-15
2025-12-31	$402,840	74,600	0.0%	Shares	Sole	2026-02-17
2025-09-30	$364,794	74,600	+16.4%	Shares	Sole	2025-11-14
2025-06-30	$301,270	64,100	+63.9%	Shares	Sole	2025-08-14
2025-03-31	$142,715	39,100	+16.7%	Shares	Sole	2025-05-15
2024-12-31	$158,120	33,500	-42.7%	Shares	Sole	2025-02-14
2024-09-30	$544,635	58,500	+1.7%	Shares	Sole	2024-11-14
2024-06-30	$330,625	57,500	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.